Clinical trials
Recruiting Phase 3 ST Elevation Myocardial Infarction trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 5 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 10 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Instituto Mexicano del Seguro Social | 2 |
| Ain Shams University | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Montreal Heart Institute | 1 |
| National Institute of Cardiovascular Diseases, Pakistan | 1 |
| Novartis Pharmaceuticals | 1 |
| Ottawa Heart Institute Research Corporation | 1 |
| Thomas Engstrom | 1 |
| University of Sydney | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| ST Elevation Myocardial Infarction | 10 |
| Myocardial Infarction | 3 |
| Non-ST Elevated Myocardial Infarction | 3 |
| Acute Coronary Syndrome | 1 |
| Hemorrhage | 1 |
| Hyperlipidemias | 1 |
| No-Reflow Phenomenon | 1 |
| Ventricular Dysfunction, Left | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.